Technical Analysis for ABMD - ABIOMED, Inc.
|Grade||Last Price||% Change||$ Change|
ABMD closed down 0.09 percent on Thursday, February 23, 2017, on 67 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Trend Table & Recent Alerts
|Weak or Absent||Up||Up||Up|
|See historical ABMD trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 23||Upper Bollinger Band Walk||Other||0.00%|
|Feb 23||180 Bullish Setup||Bullish Swing Setup||0.00%|
|Feb 22||NR7||Range Contraction||-0.09%|
|Feb 22||Narrow Range Bar||Range Contraction||-0.09%|
|Feb 22||Bearish Engulfing||Bearish||-0.09%|
|Feb 22||Stochastic Sell Signal||Bearish||-0.09%|
|Feb 22||Upper Bollinger Band Walk||Other||-0.09%|
|Feb 17||50 DMA Support||Bullish||0.27%|
|Feb 17||200 DMA Support||Bullish||0.27%|
|Feb 17||Stochastic Reached Overbought||Other||0.27%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ABMD news...
|52 Week High||132.95|
|52 Week Low||79.62|
|200-Day Moving Average||113.48|
|50-Day Moving Average||112.56|
|20-Day Moving Average||109.89|
|10-Day Moving Average||112.66|
|Average True Range||2.8|
|Chandelier Exit (Long, 3 ATRs)||109.76|
|Chandelier Exit (Short, 3 ATRs)||111.93|
|Upper Bollinger Band||118.34|
|Lower Bollinger Band||101.44|
|Percent B (%b)||0.91|